Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year net income growth rate
Percentile
P13
Within normal range
vs 2Y Ago
-15x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -70.36% |
| Q3 2025 | -120.26% |
| Q2 2025 | -126.22% |
| Q1 2025 | 248.92% |
| Q4 2024 | 156.32% |
| Q3 2024 | 21.28% |
| Q2 2024 | 5.19% |
| Q1 2024 | 3.86% |
| Q4 2023 | 4.68% |
| Q3 2023 | 0.84% |
| Q2 2023 | -9.80% |
| Q1 2023 | -4.08% |
| Q4 2022 | -12.68% |
| Q3 2022 | -3.21% |
| Q2 2022 | -10.60% |
| Q1 2022 | -2.10% |
| Q4 2021 | -18.16% |
| Q3 2021 | -7.78% |
| Q2 2021 | -49.93% |
| Q1 2021 | 37.55% |
| Q4 2020 | -199.73% |
| Q3 2020 | -22.26% |
| Q2 2020 | -24.69% |
| Q1 2020 | 0.00% |